WORLDSymposium 2017 Satellite Symposia
14 Satellite symposia were held from Monday, February 13, 2017 to Thursday, February 16, 2017. Click here for the full schedule.
WORLDSymposium 2017 New Treatment Award
The WORLDSymposium 2017 New Treatment Award was presented to migalastat (Galafold™). More details.
WORLDSymposium 2017 Exhibitors
WORLDSymposium 2017 attracted over 25 Exhibitors and 9 Patient Advocate Groups. View 2017 Exhibitor List.
WORLDSymposium 2017 Program
Following the presentation of the Award for Innovation and Accomplishment in lysosomal disease research, presentations in the morning and afternoon sessions will discuss innovations in technology and how they can be applied to early diagnosis for lysosomal conditions, progress in gene therapy, and exploitation of differences at the cellular level that may indicate early disease state. View full program.
WORLDSymposium 2017 Emerging Trends
For the fifth consecutive year, WORLDSymposium began with Emerging Trends in Lysosomal Biology & Lysosomal Diseases: State-of-the-art for Experts on Monday, February 13, 2017. See agenda and faculty.
WORLDSymposium 2017 Roscoe O. Brady Award
WORLDSymposium 2017 Roscoe O. Brady Award was presented to Konrad Sandhoff, PhD on Tuesday, February 14, at 7:45 AM, followed by a scientific presentation by Dr. Sandhoff. View details.
WORLDSymposium 2017 Poster Sessions
WORLDSymposium 2017 had 378 scientific abstracts presented at two (2) separate poster sessions. View 2017 Poster List.
WORLDSymposium 2017 Keynote Speakers
Dr. Elsa Shapiro’s Keynote Address: Understanding and Measuring Neurodegeneration in Childhood Onset Lysosomal Diseases, was on Wednesday, February 15, 2017 at 7:45 AM as well as Dr. Richard Moscicki’s Keynote Address: An FDA Perspective on Rare Disease Drug Development, was on Thursday, February 16, 2017, from 7:45-8:15 AM. Read speaker bios.
WORLDSymposium 2017 Young Investigator Awards
WORLDSymposium was pleased to announce the 10 recipients of the 2017 Young Investigator Awards on Thursday, February 16, 2017. More details.
WORLDSymposium 2017 Patient Advocate Leader (PAL) Award
WORLDSymposium 2017 Patient Advocate Leader (PAL) Award was received by Christine Lavery, MBE on Thursday, February 16, 2017. Christine Lavery founded the United Kingdom (UK) Society for Mucopolysaccharide Diseases (MPS Society) in 1982 following the death of her firstborn son, Simon, from Hunter disease. More details.